These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 645575)

  • 1. Electrophysiologic properties of a new antiarrhythmic drug--tocainide.
    Moore EN; Spear JF; Horowitz LN; Feldman HS; Moller RA
    Am J Cardiol; 1978 Apr; 41(4):703-9. PubMed ID: 645575
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiologic effects of encainide (MJ 9067) on canine Purkinje fibres.
    Gibson JK; Somani P; Bassett AL
    Eur J Pharmacol; 1978 Nov; 52(2):161-9. PubMed ID: 729630
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
    Koerpel BJ; Davis LD
    Circ Res; 1972 Jun; 30(6):681-9. PubMed ID: 5025676
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of the new antiarrhythmic drug 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide++ + on dog cardiac muscle.
    Sato Y; Iijima T; Taira N
    Arzneimittelforschung; 1989 Jan; 39(1):56-9. PubMed ID: 2719743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
    Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
    Spear JF; Moore EN
    Pacing Clin Electrophysiol; 1982 Mar; 5(2):238-50. PubMed ID: 6176964
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
    Somani P; Kumakura S
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():367-85. PubMed ID: 4806661
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers.
    Arnsdorf MF
    J Pharmacol Exp Ther; 1977 Jun; 201(3):689-700. PubMed ID: 577217
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac electrophysiologic effects of R 54718.
    Johnson N; Spinelli W; Rosen MR
    Eur J Pharmacol; 1987 Mar; 135(1):41-51. PubMed ID: 3569425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
    Carmeliet E
    Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine.
    Rosen MR; Hoffman BF; Wit AL
    Am Heart J; 1975 Apr; 89(4):526-36. PubMed ID: 1090140
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of the electrophysiologic matrix by antiarrhythmic drugs.
    Hoffman BF
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):28B-30B. PubMed ID: 3923078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
    Arnsdorf MF; Sawicki GJ
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1158-66. PubMed ID: 2495352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Dec; 90(6):795-803. PubMed ID: 903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.